Profits increased due to the PLI incentive and cost optimization, while sales have gone down due to the high base effect | Glenmark Life Sciences Q1 FY23 Result & Earning Call Highlights
Profits increased due to the PLI incentive and cost optimization, while sales have gone down due to the high base effect | Glenmark Life Sciences Q1 FY23 Result & Earning Call Highlights
Profits increased due to the PLI incentive and cost optimization, while sales have gone down due to the high base effect | Glenmark Life Sciences Q1 FY23 Result & Earning Call Highlights